GPF Test for Inflammatory Diseases

About Gamma Diagnostics

Gamma Diagnostics is a private, commercial-stage diagnostics company specializing in the Gamma Prime Fibrinogen (GPF) biomarker. Its core product is the GammaCoeur test kit, designed to predict thrombotic risk and inflammation severity in cardiovascular disease and conditions like COVID-19. The company leverages foundational research from its founder and aims to empower clinicians with better predictive tools. It operates as a commercial entity selling diagnostic kits, with a leadership team experienced in diagnostics, research, and business development.

Therapeutic Areas